Dead Sea climatotherapy combines bathing, controlled sun exposure, and medical care, with research focused especially on psoriasis. A controlled trial found a modest benefit from adding Dead Sea salt soaks before narrowband UVB treatment, but no clinically important difference in clearance or time to relapse.
What the controlled study tested
In a 2005 paired controlled study, researchers enrolled 60 people with chronic plaque psoriasis. They compared narrowband ultraviolet B (UVB) treatment alone with the same UVB treatment preceded by Dead Sea salt soaks. The combined treatment produced a slightly greater reduction in disease severity over the treatment course. The trial’s published abstract in PubMed reports that the difference in clearance and time to relapse was not clinically important.
This comparison tests a salt soak as an addition to UVB, not the effect of every Dead Sea product or a mineral cream sold to visitors. The broader clinical review in the Israel Medical Association Journal describes psoriasis climatotherapy among several available treatments. An earlier clinical report on Dead Sea climatotherapy also assessed treatment outcomes.
Why medical supervision matters
Climatotherapy involves several exposures at once: bathing, sunlight, and sometimes prescribed phototherapy. Sunlight and medical UVB can damage skin, and a person’s medications, skin sensitivity, psoriasis severity, and other health conditions affect the appropriate plan. Dead Sea bathing is not a cure and should not replace prescribed care.
People considering a treatment program should discuss it with a qualified clinician, including how UV exposure will be measured and how the plan fits existing treatment. For the region’s geology and water-related hazards, see how the Dead Sea basin formed and how sinkholes develop along its shore.